APIM Therapeutics AS

Apim Therapeutics

This clinical-stage biotechnology company develops peptide drugs targeting cellular stress responses for patients with advanced cancers including ovarian cancer and sarcoma.

Targovax AS (Oncos)

This biotechnology company develops circular RNA therapeutics and oncolytic virus-based immunotherapies for patients with solid tumours and other difficult-to-treat diseases.

Aprea Therapeutics

This company develops targeted cancer therapies for patients with biomarker-defined tumours and DNA damage response pathway defects.

Pep-Therapy

This biotechnology company develops intracellular peptide-based targeted therapies to treat patients with advanced solid tumours, including pancreatic and ovarian cancers.

Oncopeptides AB

This biotech company develops targeted therapies for patients with difficult-to-treat hematological diseases, specifically focusing on multiple myeloma treatments.

Cytovation AS

This company develops peptide-based immunotherapy treatments for patients with solid tumours and cancers driven by the Wnt/β-catenin signalling pathway.

TwoStep Therapeutics

The company develops peptide-drug conjugates and targeted therapies for patients with solid tumours.

Apoxis SA

This company develops therapeutic proteins and small molecules for the treatment of cancer and inflammatory diseases in clinical-stage patients.